Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Think Research Corporation V.THNK

Think Research Corporation is a Canada-based company that offers digital health software solutions. It is a provider of cloud-based data, knowledge, and software solutions primarily delivered as software-as-a-service (SaaS) to healthcare delivery systems and the practitioners that they support. Its operations are organized into three lines of business: Software and Data Solutions, Clinical Research, and Clinical Services. Its SaaS solutions help patients find, navigate, and connect to health services across large governments and payer clients, while also ensuring safety for prescribed medications at pharmacies. Through its wholly owned subsidiary, BioPharma Services Inc., the Company provides research data and analysis derived from Phase I clinical trials, bioequivalence studies and bioanalytical services. Its clinics act as a test bed for its software and technology, transforming them with digital solutions that optimize clinical outcomes, streamline workflows, and optimize billing.


TSXV:THNK - Post by User

Comment by dt_coreon May 29, 2022 8:20pm
121 Views
Post# 34715930

RE:Let's see if this works. Trying to post the results:

RE:Let's see if this works. Trying to post the results:Trying again:

GAAP Income Statement

Think Research Corporation
Unaudited Condensed Consolidated Interim Statements of Operations and
Comprehensive Income (Loss)
(In thousands of Canadian dollars and thousands of shares, except per share amounts)
Three months ended March 31, 2022

Revenue: $20,204 
Cost of sales: $11,090 
Gross profit: $9,114

Operating expenses
General and administration $6,242
Research and development $1,894
Sales and marketing $2,315
Depreciation and amortization $3,636
Total operating expenses$14,087
Loss before other expenses and income taxes $(4,973)

Other expenses
Acquisition, restructuring and other $1,062
Finance costs $1,076
Total other expenses $2,138

Net income (loss) before income tax $(7,111)
Income tax expense (recovery) $(913)

Net income (loss) for the period(6,198)
Other comprehensive income (loss) Item that may be subsequently reclassified to profit:Foreign currency translation differences for foreign $42

Comprehensive income (loss) for the period $(6,156)
Net loss per share - basic and diluted (0.11)


 
<< Previous
Bullboard Posts
Next >>